PURPOSE: Our aim was to assess the feasibility of intraoperative radioguidance with a portable gamma camera during laparoscopic sentinel node (SN) procedures in urological malignancies. METHODS: We evaluated the use of the intraoperative portable gamma camera in 20 patients: 16 patients with prostate carcinoma (PCC), 2 patients with renal cell carcinoma (RC) and 2 patients with testicular cancer (TC). Intra/peritumoural injection of (99m)Tc-nanocolloid ((99m)Tc) was followed by planar lymphoscintigraphy, SPECT/CT and marking of SN levels. Before laparoscopy a (125)I seed was fixed on the laparoscopic gamma probe as a pointer of SN seeking. The portable gamma camera was set to display the (99m)Tc signal for SN localisation and the (125)I signal for SN seeking. Matching of these signals on screen indicated exact SN localisation, and consequently this SN was removed. RESULTS: The mean injected dose was 218 MBq in PCC, 228 MBq in RC and 88 MBq in TC. Pelvic SN were visualised in all PCC patients, with uncommonly located SN in seven patients. SN metastases were found in seven patients (one in a uncommonly located SN). Both RC patients and TC patients had para-aortic SN, which were all tumour free. A total of 59 SN were removed. The portable gamma camera enabled real-time SN display/identification in 18 patients (90%). CONCLUSION: The use of a portable gamma camera in combination with a laparoscopic gamma probe incorporates intraoperative real-time imaging with improved SN identification in urological malignancies. This procedure might also be useful for SN identification of other deep draining malignancies.
PURPOSE: Our aim was to assess the feasibility of intraoperative radioguidance with a portable gamma camera during laparoscopic sentinel node (SN) procedures in urological malignancies. METHODS: We evaluated the use of the intraoperative portable gamma camera in 20 patients: 16 patients with prostate carcinoma (PCC), 2 patients with renal cell carcinoma (RC) and 2 patients with testicular cancer (TC). Intra/peritumoural injection of (99m)Tc-nanocolloid ((99m)Tc) was followed by planar lymphoscintigraphy, SPECT/CT and marking of SN levels. Before laparoscopy a (125)I seed was fixed on the laparoscopic gamma probe as a pointer of SN seeking. The portable gamma camera was set to display the (99m)Tc signal for SN localisation and the (125)I signal for SN seeking. Matching of these signals on screen indicated exact SN localisation, and consequently this SN was removed. RESULTS: The mean injected dose was 218 MBq in PCC, 228 MBq in RC and 88 MBq in TC. Pelvic SN were visualised in all PCC patients, with uncommonly located SN in seven patients. SN metastases were found in seven patients (one in a uncommonly located SN). Both RC patients and TCpatients had para-aortic SN, which were all tumour free. A total of 59 SN were removed. The portable gamma camera enabled real-time SN display/identification in 18 patients (90%). CONCLUSION: The use of a portable gamma camera in combination with a laparoscopic gamma probe incorporates intraoperative real-time imaging with improved SN identification in urological malignancies. This procedure might also be useful for SN identification of other deep draining malignancies.
Authors: P Paredes; S Vidal-Sicart; G Zanón; N Roé; S Rubí; S Lafuente; J Pavía; F Pons Journal: Eur J Nucl Med Mol Imaging Date: 2007-11-28 Impact factor: 9.236
Authors: Stefan Corvin; David Schilling; Kai Eichhorn; Ilse Hundt; Joerg Hennenlotter; Aristotelis G Anastasiadis; Markus Kuczyk; Roland Bares; Arnulf Stenzl Journal: Eur Urol Date: 2005-12-09 Impact factor: 20.096
Authors: Alberto Briganti; Felix K-H Chun; Andrea Salonia; Nazareno Suardi; Andrea Gallina; Luigi Filippo Da Pozzo; Marco Roscigno; Giuseppe Zanni; Luc Valiquette; Patrizio Rigatti; Francesco Montorsi; Pierre I Karakiewicz Journal: Eur Urol Date: 2006-08-31 Impact factor: 20.096
Authors: Neivo Silva; Carlos E Anselmi; Osvaldo E Anselmi; Rafael R Madke; Angela Hunsche; Jose S Souto; Carlos A V Souto; Dante Sica F; Giovani T Pioner; Edson C Macalos; Antonio A Hartmann; Mauricio S Lima Journal: Nucl Med Commun Date: 2005-12 Impact factor: 1.690
Authors: Willem Meinhardt; Renato A Valdés Olmos; Henk G van der Poel; Axel Bex; Simon Horenblas Journal: BJU Int Date: 2008-04-10 Impact factor: 5.588
Authors: Thijs Engelen; Beatrice Mf Winkel; Daphne Dd Rietbergen; Gijs H KleinJan; Sergi Vidal-Sicart; Renato A Valdés Olmos; Nynke S van den Berg; Fijs Wb van Leeuwen Journal: Am J Nucl Med Mol Imaging Date: 2015-02-15
Authors: Xinning Wang; Steve S Huang; Warren D W Heston; Hong Guo; Bing-Cheng Wang; James P Basilion Journal: Mol Cancer Ther Date: 2014-09-19 Impact factor: 6.261
Authors: Thomas Wendler; Ken Herrmann; Andreas Schnelzer; Tobias Lasser; Joerg Traub; Olivier Kutter; Alexandra Ehlerding; Klemens Scheidhauer; Tibor Schuster; Marion Kiechle; Markus Schwaiger; Nassir Navab; Sibylle I Ziegler; Andreas K Buck Journal: Eur J Nucl Med Mol Imaging Date: 2010-03-31 Impact factor: 9.236
Authors: Kosta Popovic; Jack E McKisson; Brian Kross; Seungjoon Lee; John McKisson; Andrew G Weisenberger; James Proffitt; Alexander Stolin; Stan Majewski; Mark B Williams Journal: IEEE Trans Nucl Sci Date: 2014-05-20 Impact factor: 1.679
Authors: Axel Bex; Lenka Vermeeren; Geraldine de Windt; Warner Prevoo; Simon Horenblas; Renato A Valdés Olmos Journal: Eur J Nucl Med Mol Imaging Date: 2010-01-29 Impact factor: 9.236
Authors: L Vermeeren; W M C Klop; M W M van den Brekel; A J M Balm; O E Nieweg; R A Valdés Olmos Journal: J Oncol Date: 2009-11-09 Impact factor: 4.375